Peptides are a group of biologically active substances that are involved in various cellular functions of organisms.Peptides are frequently utilized in functional analysis, research on vaccines, and particularly in the production of pharmaceuticals. More than 80 peptide medications are already available on the market to treat a variety of illnesses, such as diabetes, cancer, osteoporosis, multiple sclerosis, HIV infection, and chronic pain.
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
V36664 | (Dap22)-Stichodactyla helianthus Neurotoxin (ShK) | 220384-25-8 | (Dap22)-Stichodactyla helianthus Neurotoxin (ShK) is a peptide compound. | |
V36829 | (Des-acetyl)-α-MSH | 53697-27-1 | (Des-acetyl)-α-MSH is a bioactive peptide discovered by peptide screening. | |
V37003 | (DES-ALA1,DES-GLY2,HIS4,5,D-TRP8)-SOMATOSTATIN-14 | 68463-41-2 | Wy 41747 is a long-acting somatostatin analog. | |
V36438 | (Des-Arg30,Des-Pro31)-Dendroaspis Natriuretic Peptide | (Des-Arg30,Des-Pro31)-Dendroaspis Natriuretic Peptide is a peptide compound. | ||
V34925 | (Des-Arg9,Leu8)-Bradykinin | 64695-06-3 | (Des-Arg9,Leu8)-Bradykinin is a peptide compound. | |
V34890 | (Des-Asp1)-Angiotensin I | 56317-01-2 | (Des-Asp1)-Angiotensin I is a peptide compound. | |
V34895 | (Des-Asp1,Ile8)-Angiotensin II|Angiotensin III | 52498-25-6 | (Des-Asp1,Ile8)-Angiotensin II|Angiotensin III is a peptide compound. | |
V36583 | (Des-Asp187)-Melanocyte Protein PMEL 17 (185-193) (human, bovine, mouse) | 319927-23-6 | (Des-Asp187)-Melanocyte Protein PMEL 17 (185-193) (human, bovine, mouse) is a peptide compound. | |
V36584 | (Des-Asp187,Met186)-Melanocyte Protein PMEL 17 (185-193) (human, bovine, mouse) | 255710-51-1 | (Des-Asp187,Met186)-Melanocyte Protein PMEL 17 (185-193) (human, bovine, mouse) is a peptide compound. | |
V34953 | (Des-Cys1,cyclo(Ser2-Asu7))-Calcitonin (eel) | 60731-46-6 | (Des-Cys1,cyclo(Ser2-Asu7))-Calcitonin (eel) is a peptide compound. | |
V36802 | (Des-His1,Glu9)-Glucagon (1-29) amide (human, rat, porcine) | 110084-95-2 | Des-His1,Glu9)-Glucagon (1-29) amide (human, rat, porcine) is a peptide compound acting as aglucagon receptor antagonist with a pA2 of 7.2 for inhibition of glucagon-induced adenylyl cyclase activation in rat liver membranes and displays no agonist activity. | |
V36527 | (Des-Leu9)-Kinetensin | (Des-Leu9)-Kinetensin is a peptide compound. | ||
V36399 | (Des-Ser1)-Cerebellin | 94245-80-4 | (Des-Ser1)-Cerebellin is a peptide compound. | |
V36799 | (Des-Thr5)-Glucagon | 1802078-27-8 | (Des-Thr5)-Glucagon is a bioactive peptide discovered by peptide screening. | |
V36800 | (Des-Thr7)-Glucagon | 1802078-28-9 | (Des-Thr7)-Glucagon is a bioactive peptide discovered by peptide screening. | |
V36830 | (Diacetyl)-α-MSH | 71952-90-4 | (Diacetyl)-α-MSH is a bioactive peptide compound that introduces an oxalyl (Diacetyl) group into the α-MSH molecule to increase the bioactivity of the peptide. | |
V37054 | (DL-Isoser1)-TRAP-6 | 150242-29-8 | iso-TRAP-6 (iso-SFLLRN) is a PAR-1 agonist that activates/agonizes platelets. | |
V36376 | (Fmoc-Glu70,Ala71·72,Lys74)-C3a (70-77) | (Fmoc-Glu70,Ala71·72,Lys74)-C3a (70-77) is a peptide compound. | ||
V36640 | (Gln18)-Platelet Factor 4 (15-22) (human) | 144207-60-3 | (Gln18)-Platelet Factor 4 (15-22) (human) is a peptide compound. | |
V36457 | (Glu1)-Fibrinopeptide B | 103213-49-6 | [Glu1]-Fibrinopeptide B is developed from fibrinopeptide B amino acid (AA) residues 1-14. |